World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   40629 records for 17026 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
Not recruitingNoNCT03045926
Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea
03/02/2017
Not recruitingYesNCT03044795
Response to PARP Inhibitor Predicted by the RAD51 Assay
02/02/2017
RecruitingNoISRCTN10145611
Implementation of oral care in primary diabetes care in the Netherlands
01/02/2017
RecruitingYesISRCTN14282228
Hospitality project (HY): Combining peer support and home-based skill training in people with schizophrenia
31/01/2017
RecruitingNoNCT03043846
Treat to Target Trial in Axial Spondylo Arthritis : The TICOSPA (Tight Control in Spondyloarthritis)
31/01/2017
Not RecruitingNoISRCTN15427669
Electronic continuous pain measurement versus Verbal Rating Scale in gynaecology
30/01/2017
Not recruitingYesNCT03042572
Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
27/01/2017
RecruitingNoNCT03038230
MCLA-117 in Acute Myelogenous Leukemia
26/01/2017
RecruitingYesNCT03036501
A Study Investigating the Excretion Balance, Pharmacokinetics and Metabolism of a Single Oral Dose of [14C]-Labeled RO7034067 in Healthy Male Participants
26/01/2017
AuthorisedYesEUCTR2016-001965-98-NL
A randomized and open-label dose-finding study to see whether AFN-RHO works, is safe to use and to see how long the drug remains in the body of patients suffering from stage II, III or IV breast cancer who have a high risk of neutropenia due to chemotherapy. AFN-RHO is compared to pegfilgrastim.
26/01/2017
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history